NERV
NERV clinical trials: Minerva Neurosciences, Inc.
Every trial on ClinicalTrials.gov where Minerva Neurosciences, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 7
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
NERV on the catalyst calendar · NERV registry changes
- Primary completion Dec 2027Sponsor estimatePhase 3NCT07565428Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of...Minerva Neurosciences · Negative Symptoms of SchizophreniaRecruitingNERVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 12, 2024ActualPhase 1NCT06107803A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine...Minerva Neurosciences · Negative Symptoms in SchizophreniaCompletedNERVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 26, 2020ActualPhase 3NCT03397134Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of SchizophreniaMinerva Neurosciences · Negative Symptoms of SchizophreniaCompletedNERVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 21, 2019ActualPhase 2NCT03446846A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive DisorderMinerva Neurosciences · Major Depressive DisorderCompletedNERVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 7, 2017ActualPhase 1NCT03072056A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive MetabolizersMinerva Neurosciences · Healthy SubjectsCompletedNERVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 20, 2017ActualPhase 1NCT03038646A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy SubjectsMinerva Neurosciences · Healthy SubjectsCompletedNERVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2015ActualPhase 1NCT02232529Pharmacokinetic Study of MIN-101 in Healthy SubjectsMinerva Neurosciences · SchizophreniaCompletedNERVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner